Frontlight ResearchEarly access
Cervical cancer trials in Italy
23 of 40 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Bergamo, Genova, Naples, Verona
- Age
- 18 years and over
- People
- 890 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - Phase 3Taking peopleA Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Where
- Aviano, Brescia, Catania, Meldola, Milan, Padova, Rome, Treviso, Turin
- Age
- 18 years and over
- People
- 1,023 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07216703 · EU 2025-521514-26-00 - Phase 3Taking peopleStudy of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
- Where
- Bologna, Catania, Florence, Lecco, Milan, Monza, Naples, Rome, Turin
- Age
- 15 years and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06079671 · EU 2023-504374-38-00 - Phase 1Taking peopleA Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Where
- Milan
- Age
- 18 years and over
- People
- 575 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00 - Phase 2Taking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Milan, Reggio Emilia, Rome
- Age
- 18 years and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - No phaseNot yet taking people in ItalyGut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers
- Where
- Milan
- Age
- 18 years and over
- People
- 360
- Run by
- European Institute of Oncology
See details and how to joinNCT07815873 - Phase 2Not yet taking people in ItalyDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Bergamo, Brescia, Ferrara, Florence, Milan, Modena, Pavia, Verona
- Age
- 18 years and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - No phaseTaking peopleBenefits of cinEmA Sessions During Radio-chemoTherapy on Outcomes of Patients With ceRvIcal canCEr
- Where
- Roma
- Age
- 18 years to 70 years
- People
- 68
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07902180 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Candiolo, Milan, Naples, Rome, Rozzano
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 3Not yet taking people in ItalyPARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
- Where
- Roma
- Age
- 18 years and over
- People
- 510 worldwide
- Run by
- Institut Claudius Regaud
See details and how to joinNCT05581121 - Phase 2Taking peoplePhase II study of Cemiplimab before and after standard chemoradiotherapy for patients with locally advanced cervical carcinoma. CADILLACC TRIAL
- Where
- Brescia, Como, Lecco, Milan, Varese
- Age
- 18 years to 64 years
- People
- 29
- Run by
- Fondazione IRCCS Istituto Nazionale Dei Tumori
See details and how to join2025-521839-36-00 - Phase 1Taking peopleEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Where
- Candiolo, Rozzano
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT05983432 - Phase 2Taking peopleStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Alexandria, Bergamo, Orbassano
- Age
- 18 years to 64 years
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Candiolo, Milan, Naples, Roma, Rozzano, Siena
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - Phase 1/2Taking peopleFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Where
- Alexandria, Brescia, Milan, Monza, Pisa, Ravenna, Rome, Verona
- Age
- 18 years and over
- People
- 880 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00 - Phase 2Not yet taking people in ItalyFIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- Where
- Rome
- Age
- 18 years to 40 years
- People
- 31 worldwide
- Run by
- University Health Network, Toronto
See details and how to joinNCT04016389 · EU 2023-507230-24-00 - No phaseTaking peopleMinimally Invasive Pelvic Exenteration in Vaginal or Cervical Cancer Recurrence
- Where
- Rome
- Age
- 18 years and over
- People
- 64
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06867445 - No phaseNot yet taking people in ItalyUltrasound Training Program for Gynecologic Cancer Staging in Residents
- Where
- Roma
- Age
- 18 years and over
- People
- 6
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07028229 - No phaseNot yet taking people in ItalyTherapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr
- Where
- Rome
- Age
- 20 years to 70 years
- People
- 240 worldwide
- Run by
- CHA University
See details and how to joinNCT05421650 - No phaseNot yet taking people in ItalyEvaluation of the Diagnostic and Prognostic Value of Immunohistochemical Markers in Precancerous Lesions of the Cervix
- Where
- Bologna
- Age
- 18 years and over
- People
- 100
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06852157 - No phaseTaking peopleMinimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer
- Where
- Roma
- Age
- 18 years and over
- People
- 974
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06416748 - Phase 3Not yet taking people in ItalyIntermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy
- Where
- Rome
- Age
- 18 years to 85 years
- People
- 514 worldwide
- Run by
- The Central and Eastern European Gynecologic Oncology Group
See details and how to joinNCT04989647 · EU 2023-504973-19-01 - Phase 3CompletedImpact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia. HOPE9
- Where
- Alba, Massa, Milan, Naples, Palermo, Rome, Treviso
- Age
- 18 years and over
- People
- 1,220
- Run by
- Alessandro Ghelardi
See details and how to joinNCT03848039 · EU 2024-513704-34-00